Prot#16970: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SAR443820 in Adult Participants with Amyotrophic Lateral Sclerosis, Followed by an Open-Label Extension

Project: Research project

Project Details

StatusActive
Effective start/end date3/29/22 → 7/31/25

Funding

  • Sanofi US Services Inc. (Prot#16970)